FINNENCE ▪ THE WIRE FILE

THE WIRE · № 67855

News▲ Bullish

Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by Wissen Research

1 SOURCE CONFIRMED · FIRST SEEN 2026-10-06 18:35 UTC

EXHIBIT · mmx.prnewswire.com

KINDNews

DIRECTION▲ Bullish

SOURCES1

ENTITIES1

STORY SIZESTANDALONE

FIRST SEEN2026-10-06 18:35 UTC

LAST UPDATE2026-10-06 18:35 UTC

STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Projected growth in drug delivery devices points to expanding medtech demand, relevant to device and pharma supply chains.

Structural growth forecast for drug delivery devices

CATALYST TO WATCH

Adoption of smart and wearable devices

MAIN RISK

Forecast optimism not matched by actual sales

FULL DISPATCH

SHERIDAN, Wyo., Oct. 6, 2026 /PRNewswire/ -- The global drug delivery devices market is projected to grow from USD 488.6 billion in 2026 to USD 698.2 billion by 2031, registering a CAGR of 7.4% during the forecast period (2026–2031), according to a new study by Wissen Research. Growth is...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED

№ 01prnewswireprnewswire.com · PRIMARY2026-10-06 18:35 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation2026-10-06 18:39 UTC

←CORRELATIONshares Healthcare
New Phase 3 trial: J-LINX: Japan LINerixibat eXtension Study — GlaxoSmithKline2026-10-06 12:00 UTC

←CORRELATIONshares Healthcare
New Phase 3 trial: A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity — Novo Nordisk A/S2026-10-06 12:00 UTC

←CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury — Pharmazz, Inc.2026-10-06 12:00 UTC

←CORRELATIONshares Healthcare
Phase 3 results posted: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery — Vascular Therapies, Inc.2026-10-06 12:00 UTC

←CORRELATIONshares Healthcare
Phase 3 results posted: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Janssen Research & Development, LLC2026-10-06 12:00 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.